Thanks. So it’s important to know when the 26th gets included and expected follow up from the time of 26th starting in trial to estimate conservative time frame. Median duration of gem/nab paclitaxel in the original Mpact trial was 4 months. So if we use that assumption, and ATX saying mid- year for results, let’s say June 30, working back 4 months means 26th should have been enrolled end Feb.
However if they get lucky and all 6 + objective responses they need to pass futility occur in first handful of patients, that’s great!
Thanks. So it’s important to know when the 26th gets included...
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
-0.001(0.83%) |
Mkt cap ! $16.43M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 6.0¢ | 5.9¢ | $1.439K | 24.22K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 36500 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 114727 | 1 |
View Market Depth
| Last trade - 10.11am 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.9¢ |
Change
-0.001 ( 3.28 %) |
||||
| Open | High | Low | Volume | ||
| 6.0¢ | 6.0¢ | 5.9¢ | 52400 | ||
| Last updated 10.26am 17/05/2024 ? | |||||
| ATX (ASX) Chart |